Resmed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered ...

Both of these names are well on the growth route from 2025. The post Brokers rate these 2 ASX growth stocks as top buys ...

SBI Securities Co. Ltd. acquired a new position in shares of ResMed Inc. (NYSE:RMD – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange ...

Shares of ResMed Inc. (NYSE:RMD – Get Free Report) have earned a consensus rating of “Moderate Buy” from the fifteen research ...

Resmed, a leader in health technology focused on sleep and respiratory care, has announced a significant brand evolution aimed at unifying its portfolio and enhancing direct consumer engagement ...

Resmed, a leader in sleep technology, has unveiled its latest global health consumer campaign, ‘Say goodbye to your sleep monster’ via the aptly named independent creative agency Hopeful ...

Learn More ResMed Inc (ASX: RMD) shares are in the red so far in 2025. After slipping from 52-week highs of $40.50 in January, shares in the respiratory device company currently fetch $35.71 apiece.

ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the ...

SINGAPORE: A recent study has shed light on the widespread sleep issues plaguing Singapore, with a concerning number of ...

These include a sustainable business model, a long track of profitability, rising cash flows, good liquidity, a strong balance sheet and some value characteristics. A history of strong dividend growth ...